Lung cancer treatment from home: a new trial explores telemedicine drug delivery
NCT ID NCT05340309
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study tests whether a cancer drug called atezolizumab can be given safely at home to people with non-small cell lung cancer. Instead of going to a clinic, patients receive the injection under the skin from a nurse while using telemedicine. The goal is to see if this home-based approach is practical and keeps patients safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.